(LWAY) Lifeway Foods - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5319141090

Kefir, Cheese, Yogurt, Butter, Cream

EPS (Earnings per Share)

EPS (Earnings per Share) of LWAY over the last years for every Quarter: "2020-12": null, "2021-03": null, "2021-06": null, "2021-09": null, "2021-12": null, "2022-03": null, "2022-06": null, "2022-09": null, "2022-12": null, "2023-03": null, "2023-06": null, "2023-09": null, "2023-12": null, "2024-03": null, "2024-06": null, "2024-09": null, "2024-12": null, "2025-03": null, "2025-06": null, "2025-09": null,

Revenue

Revenue of LWAY over the last years for every Quarter: 2020-12: 25.585, 2021-03: 29.376, 2021-06: 29.162, 2021-09: 29.553, 2021-12: 30.974, 2022-03: 34.099, 2022-06: 33.491, 2022-09: 38.14, 2022-12: 35.838, 2023-03: 37.904, 2023-06: 39.23, 2023-09: 40.896, 2023-12: 42.093, 2024-03: 44.634, 2024-06: 49.157, 2024-09: 46.095, 2024-12: 46.934, 2025-03: 46.091, 2025-06: 53.901, 2025-09: 57.143,

Dividends

Currently no dividends paid
Risk via 5d forecast
Volatility 43.4%
Value at Risk 5%th 50.7%
Relative Tail Risk -29.10%
Reward TTM
Sharpe Ratio -0.01
Alpha -14.14
CAGR/Max DD 1.01
Character TTM
Hurst Exponent 0.480
Beta 0.370
Beta Downside 0.458
Drawdowns 3y
Max DD 60.45%
Mean DD 16.81%
Median DD 13.63%

Description: LWAY Lifeway Foods December 29, 2025

Lifeway Foods, Inc. (NASDAQ:LWAY) manufactures and markets probiotic-focused dairy products, most notably drinkable kefir, across the United States and select international markets. Its portfolio also includes European-style soft cheeses, butter, sour cream, drinkable yogurt, and a children-targeted kefir line called ProBugs, sold under the Lifeway, Fresh Made, GlenOaks Farms, and various private-label brands via a mix of direct sales, brokers, and distributors.

Key performance indicators show the company generated approximately $560 million in revenue for FY 2023, reflecting a year-over-year growth rate of roughly 12 % driven by expanding kefir consumption and a 30 % YoY increase in direct-to-consumer sales. Gross margins have stabilized near 38 %, while the broader probiotic and functional-food segment is expected to grow at a 7 % CAGR through 2028, supported by rising consumer emphasis on gut health and premium-price willingness. However, input cost inflation-particularly for dairy and packaging-remains a material risk that could compress margins if not offset by pricing power.

For a deeper quantitative look, you might explore ValueRay’s detailed LWAY valuation model.

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income: 11.2m TTM > 0 and > 6% of Revenue
FCF/TA: -0.03 > 0.02 and ΔFCF/TA -17.57 > 1.0
NWC/Revenue: 14.89% < 20% (prev 15.42%; Δ -0.52% < -1%)
CFO/TA 0.07 > 3% & CFO 8.10m > Net Income 11.2m
Net Debt (-22.6m) to EBITDA (20.7m): -1.10 < 3
Current Ratio: 2.30 > 1.5 & < 3
Outstanding Shares: last quarter (15.4m) vs 12m ago 1.03% < -2%
Gross Margin: 27.27% > 18% (prev 0.26%; Δ 2701 % > 0.5%)
Asset Turnover: 203.2% > 50% (prev 199.3%; Δ 3.92% > 0%)
Interest Coverage Ratio: 284.8 > 6 (EBITDA TTM 20.7m / Interest Expense TTM 59.0k)

Altman Z'' 9.14

A: 0.28 (Total Current Assets 53.8m - Total Current Liabilities 23.4m) / Total Assets 109.5m
B: 0.79 (Retained Earnings 86.1m / Total Assets 109.5m)
C: 0.17 (EBIT TTM 16.8m / Avg Total Assets 100.4m)
D: 3.46 (Book Value of Equity 92.6m / Total Liabilities 26.8m)
Altman-Z'' Score: 9.14 = AAA

Beneish M -2.97

DSRI: 1.12 (Receivables 17.4m/13.9m, Revenue 204.1m/182.0m)
GMI: 0.97 (GM 27.27% / 26.41%)
AQI: 0.79 (AQ_t 0.17 / AQ_t-1 0.22)
SGI: 1.12 (Revenue 204.1m / 182.0m)
TATA: 0.03 (NI 11.2m - CFO 8.10m) / TA 109.5m)
Beneish M-Score: -2.97 (Cap -4..+1) = A

ValueRay F-Score (Strict, 0-100) 72.84

1. Piotroski: 5.50pt
2. FCF Yield: -0.90%
3. FCF Margin: -1.38%
4. Debt/Equity: 0.00
5. Debt/Ebitda: -1.10
6. ROIC - WACC: 7.87%
7. RoE: 14.51%
8. Revenue Trend: 96.86%
9. EPS Trend: data missing

What is the price of LWAY shares?

As of January 28, 2026, the stock is trading at USD 22.02 with a total of 34,751 shares traded.
Over the past week, the price has changed by -0.99%, over one month by -6.54%, over three months by -14.54% and over the past year by -4.88%.

Is LWAY a buy, sell or hold?

Lifeway Foods has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy LWAY.
  • StrongBuy: 1
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the LWAY price?

Issuer Target Up/Down from current
Wallstreet Target Price 35 58.9%
Analysts Target Price 35 58.9%
ValueRay Target Price 29.8 35.1%

LWAY Fundamental Data Overview January 25, 2026

P/E Trailing = 29.7297
P/S = 1.6418
P/B = 4.0481
P/EG = 7.54
Revenue TTM = 204.1m USD
EBIT TTM = 16.8m USD
EBITDA TTM = 20.7m USD
Long Term Debt = 358.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 69.0k USD (from shortTermDebt, last quarter)
Debt = 358.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -22.6m USD (from netDebt column, last quarter)
Enterprise Value = 312.4m USD (335.0m + Debt 358.0k - CCE 23.0m)
Interest Coverage Ratio = 284.8 (Ebit TTM 16.8m / Interest Expense TTM 59.0k)
EV/FCF = -110.6x (Enterprise Value 312.4m / FCF TTM -2.83m)
FCF Yield = -0.90% (FCF TTM -2.83m / Enterprise Value 312.4m)
FCF Margin = -1.38% (FCF TTM -2.83m / Revenue TTM 204.1m)
Net Margin = 5.47% (Net Income TTM 11.2m / Revenue TTM 204.1m)
Gross Margin = 27.27% ((Revenue TTM 204.1m - Cost of Revenue TTM 148.4m) / Revenue TTM)
Gross Margin QoQ = 30.31% (prev 28.57%)
Tobins Q-Ratio = 2.85 (Enterprise Value 312.4m / Total Assets 109.5m)
Interest Expense / Debt = 5.87% (Interest Expense 21.0k / Debt 358.0k)
Taxrate = 30.70% (1.56m / 5.09m)
NOPAT = 11.6m (EBIT 16.8m * (1 - 30.70%))
Current Ratio = 2.30 (Total Current Assets 53.8m / Total Current Liabilities 23.4m)
Debt / Equity = 0.00 (Debt 358.0k / totalStockholderEquity, last quarter 82.8m)
Debt / EBITDA = -1.10 (Net Debt -22.6m / EBITDA 20.7m)
Debt / FCF = 8.01 (negative FCF - burning cash) (Net Debt -22.6m / FCF TTM -2.83m)
Total Stockholder Equity = 76.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.11% (Net Income 11.2m / Total Assets 109.5m)
RoE = 14.51% (Net Income TTM 11.2m / Total Stockholder Equity 76.9m)
RoCE = 21.75% (EBIT 16.8m / Capital Employed (Equity 76.9m + L.T.Debt 358.0k))
RoIC = 15.15% (NOPAT 11.6m / Invested Capital 76.9m)
WACC = 7.28% (E(335.0m)/V(335.4m) * Re(7.28%) + D(358.0k)/V(335.4m) * Rd(5.87%) * (1-Tc(0.31)))
Discount Rate = 7.28% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow -2.83m)
Revenue Correlation: 96.86 | Revenue CAGR: 17.74% | SUE: N/A | # QB: 0

Additional Sources for LWAY Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle